Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
| Last modified: | 08 June 2017 1.25 p.m. |
More news
-
30 January 2025
Highlighted papers December 2024 - January 2025
Read our highlighted papers from December/January: new insights into electronics from 2D materials, and into the protein clumps that cause Huntington's disease.
-
28 January 2025
Studying the universe to understand the world
By understanding the cosmos, we can better fathom the fundamentals of our world. That is the idea behind the research theme Fundamentals of the Universe, in which three institutes of the University of Groningen form a unique collaboration.
-
27 January 2025
Working on better AI (with a smaller budget than the US)
The US is going to invest a staggering amount of $500 billion in AI. At the University of Groningen, researchers are working on future-proof computing: more energy-efficient hardware and responsible AI that can collaborate with humans.